Rain Enhancement Technologies Holdco Inc
Officers & Directors
1. Avanish Vellanki e CEO and President
2. Derrick Li e Chief Financial Officer
3. David L. Johnson e Chief Operating Officer
4. Brian Brewer, PhD e Chief Scientific Officer
5. Claudia Ibarra e Chief Medical Officer
Board of Directors:
1. Helen S. Kim, MD, MBA e Chairman of the Board
2. Mark R. Goldsmith, MD, PhD e Director
3. Kris Famm, PhD e Director
4. Karen Vousden, PhD e Director
5. Grant Pickering, PhD e Director
Biographies:
1. Avanish Vellanki has served as the CEO and President of Rain Therapeutics, Inc. since 2017. Prior to joining Rain, he served in various roles at Kura Oncology, Inc., Bristol-Myers Squibb, and Deloitte Consulting.
2. Derrick Li has been the CFO at Rain Therapeutics, Inc. since 2019. He previously served as the CFO of WindMIL Therapeutics and played a vital role in the successful merger of WindMIL Therapeutics and Kiadis Pharma.
3. David L. Johnson has been the Chief Operating Officer of Rain Therapeutics, Inc. since its inception. Before joining Rain, he served as the Vice President of Merck & Co.
4. Brian Brewer, PhD, joined Rain in 2018 as the Chief Scientific Officer. He has previously served as a senior leader at Infinity Pharmaceuticals and Millennium Pharmaceuticals.
5. Claudia Ibarra is the Chief Medical Officer at Rain Therapeutics, Inc. She has previously held senior positions at Bristol-Myers Squibb, Novartis, and AstraZeneca.
6. Helen S. Kim, MD, MBA, has been the Chairman of the Board at Rain Therapeutics, Inc. since 2017. She is also the Managing Director of Ivy Capital Partners and has previously served as the CEO of Collidion Inc.
7. Mark R. Goldsmith, MD, PhD, is a director at Rain Therapeutics, Inc. He has previously served as the CEO of Revolution Medicines and has held executive positions at several biotechnology companies.
8. Kris Famm, PhD, has been a director at Rain Therapeutics, Inc. since 2017. He is currently the CEO of Vesigen Therapeutics and has previously served as a senior executive at GlaxoSmithKline.
9. Karen Vousden, PhD, is a director at Rain Therapeutics, Inc. She is also the Group Leader at The Francis Crick Institute and has previously served as the Chief Scientist at Cancer Research UK.
10. Grant Pickering, PhD, has been a director at Rain Therapeutics, Inc. since 2017. He is the CEO of Lucira Health and has previously held senior positions at Gilead Sciences and Genentech.
Rain Enhancement Technologies Holdco Inc currently has 5 employees.
|
